Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of genetic diseases.

Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; pharmaceutical and biotechnology products development; research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services; software as a service services (saas) featuring artificial intelligence software for drug discovery and development.